SUSAN HOPKINS: Open Payments
NPI 1902199789 · BOONE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,784 in 138 payments from 19 companies in 2025. Trend: 2023 $2,105 · 2024 $2,455 · 2025 $2,784
Food & beverage: $2,784
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $485 |
| GENZYME CORPORATION | 9 | $313 |
| Phathom Pharmaceuticals, Inc. | 20 | $250 |
| PFIZER INC. | 12 | $246 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $182 |
| Janssen Biotech, Inc. | 6 | $180 |
| Madrigal Pharmaceuticals | 10 | $166 |
| Aimmune Therapeutics, Inc. | 7 | $149 |
| QOL Medical, LLC | 7 | $146 |
| Celltrion USA Inc. | 4 | $115 |
Products named: DUPIXENT, VOQUEZNA, RINVOQ, TREMFYA, VELSIPITY, REZDIFFRA, LINZESS, ZENPEP.
Industry payments across NC — which companies pay providers there.
